News

Bride facing eye removal has sight saved in time for wedding after cutting-edge treatment - Experts unable to pinpoint the ...
Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S Group】 announced a major milestone in veterinary drug development at the ...
Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea.
Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...
University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus ...
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...
A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...
Tech companies have been getting a lot of attention in recent weeks during the up-and-down days on Wall Street. They sometimes are among the stocks seeing the biggest moves. Try This: How To Get a ...
Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...
In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.
Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paperThe author team ...